ESMO 2026 Preview: Oncology Innovations, Clinical Trials and AI
ESMO 2026 at a glance ESMO 2026 will spotlight emerging oncology trends as…
WCLC 2026 Preview: Emerging Lung Cancer Therapies and Competitive Trends
WCLC 2026 at a glance At IASLC-WCLC 2026, where will the next wave of…
ASCO 2026: Competitive Shifts in Oncology
ASCO at a glance ASCO 2026 highlights how oncology innovation is being tested…
AACR 2026 Preview: Key Developments in Oncology and AI
AACR 2026 at a glance AACR 2026 in San Diego highlights emerging developments…
Lucid Diligence Brief: Stipple Bio $100 million Series A
Lucid Diligence Brief: Stipple Bio $100 million Series A Professional audiences…
ELCC 2026 Preview: Key Competitive Shifts in Lung Cancer
ELCC 2026 at a glance ELCC 2026 highlights key lung cancer treatment trends,…
Hematology Today—February 9, 2026
This weekly Hematology update covers regulatory actions, clinical trial…
Oncology Today—February 9, 2026
This week's Oncology update , covers regulatory actions, late-stage clinical…
Oncology Today—January 19, 2026
This week's Oncology roundup covers regulatory approvals and filings,…
Oncology 2025 Review: Curative-Intent Expansion, ADC Acceleration, and the Operationalization of Immunotherapy
The defining idea of 2025 was execution at scale—more patients pulled into…
Oncology Today—December 15, 2025
This week’s oncology update spotlights key developments, regulatory milestones,…
Oncology Today—December 1, 2025
This week’s oncology update highlights major regulatory milestones, late-stage…







